The Medicines Company has announced the appointments of Bruce Rosengard and Sanuj Ravindran as vice presidents, new business ventures. Dr. Bruce Rosengard is a cardiothoracic surgeon who joins The Medicines Company from the Massachusetts General Hospital and Harvard Medical School, where he was the Surgical Director of Cardiac Transplantation and ran an NIH-funded laboratory in transplantation immunology. Dr. Sanuj Ravindran was most recently a Managing Director at Asian Healthcare Fund.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
+0.14% | -0.05% |
2020 | The Medicines Company Announces Board Changes | CI |
2020 | The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care | CI |
1st Jan change | Capi. | |
---|---|---|
-0.05% | 6.79B | |
+16.50% | 42.2B | |
+20.78% | 21.24B | |
+20.81% | 15.89B | |
+23.69% | 14.91B | |
+57.44% | 13.1B | |
-14.94% | 6.24B | |
+21.38% | 6.08B | |
-8.87% | 5.73B | |
+25.45% | 4.56B |
- Stock Market
- Equities
- MDCO Stock
- News The Medicines Company
- The Medicines Company Announces Executive Appointments